Latest News

South Korea pledges support to biopharmaceutical and auto sectors in the face of US tariffs

South Korea pledges support to biopharmaceutical and auto sectors in the face of US tariffs

The South Korean government announced on Wednesday that it would increase support for export industries including biopharmaceutical, auto, and the biopharmaceutical sectors. These sectors are expected to suffer from U.S. President Donald Trump’s tariffs.

In a press release, the government said that it would prepare new measures for its biopharmaceutical firms as soon as Trump's tariffs in this sector are known.

Trump signed an Executive Order earlier this month to reduce the time required for approval of pharmaceutical plants within the United States. This move is part new regulations designed to encourage domestic production, following Trump's probes of pharmaceutical imports to put tariffs on that sector.

In 2024, South Korea's pharmaceutical exports will amount to $9.59 billion. This represents just 1.4% its total exports. Yet, the United States was the largest market for the country's exports, accounting for 16%.

The government also said that it would prepare additional support measures if needed to complement the earlier packages announced by last month in order to help other industries, such as automakers or chipmakers and steel producers, cope with tariffs.

Seoul, after a second round at ministerial level last week, is now holding technical discussions on a working-level with Washington. It seeks to exempt all tariffs through a comprehensive trade package that will be crafted by early July.

South Korea's exports surprised many last month. They were buoyed by a strong demand for semiconductors in spite of the U.S. trade tariffs. However, there are signs global trade tensions may be affecting its important auto sector. (Reporting and editing by Ed Davies.)

(source: Reuters)